Document Classification

Section Type: RESULTS

Text: American College of Rheumatology 20, 50, and 70 responses achieved during the DB period were maintained through the LTE, and on Day 981 were 80. 2 % (95 % CI 77. 2, 83. 2), 63. 5 % (95 % CI 58. 2, 68. 9), and 39. 5 % (95 % CI 34. 0, 44. 9) for patients who kept taking SC ABA, and 80. 0 % (95 % CI 77. 0, 83. 0), 63. 2 % (95 % CI 57. 8, 68. 7), and 39. 2 % (95 % CI 33. 7, 44. 7) for those who switched from IV to SC ABA.